Leerink Swann weighs in on Questcor Pharmaceuticals (QCOR +9.6%) after Medicaid's bump-up in...

|By:, SA News Editor

Leerink Swann weighs in on Questcor Pharmaceuticals (QCOR +9.6%) after Medicaid's bump-up in reimbursement rates, upping its revenue projection on the company to $675M from $626M and its EPS estimates from $3.67 to $4.21.